Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence (NICE guideline CG115)
This guideline cites 2 of the 62 landmark trials in our Psychiatry & psychotherapy register.
- Issued by
- NICE
- Year
- 2011
- Source
- National Institute for Health and Care Excellence. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence. NICE guideline [CG115]. Published 23 February 2011; last updated 21 October 2014; last reviewed 19 July 2019.
CG115 pairs a psychological core with an adjunctive pharmacological one: after assisted withdrawal, harmful drinking and mild dependence are treated with a psychological intervention focused on alcohol — cognitive behavioural therapy, behavioural therapies or social network and environment-based therapy — and moderate to severe dependence adds acamprosate or oral naltrexone alongside that therapy. The register trials below cover the behavioural evidence base and the combined pharmacological-behavioural comparison.
Psychological interventions for alcohol misuse1
- 1997Project MATCH CorePsychiatry · SUD · AlcoholIn 1,726 adults with alcohol use disorder, CBT, motivational enhancement therapy or twelve-step facilitation (12 weeks) produced equivalent drinking outcomes over 1-year follow-up.Read →
Combined pharmacological & behavioural treatment1
- 2006COMBINE CorePsychiatry · SUD · AlcoholIn 1,383 adults with alcohol dependence, medical management plus naltrexone or combined behavioural intervention reduced heavy-drinking days relative to placebo or acamprosate, with no additive effect.Read →
Cited landmark trials not yet in the register4
Further landmark trials this guideline cites that are not (yet) covered in our register. Each links out to the study for further reading.
- 2005UKATT
Motivational enhancement vs social behaviour and network therapy in the UK.
- 2010Rösner Cochrane review (acamprosate)
Acamprosate for alcohol dependence — the basis of the NICE recommendation.
- 2010Rösner Cochrane review (naltrexone)
Opioid antagonists for alcohol dependence.
- 1986Fuller disulfiram (VA study)
The disulfiram trial behind its restricted, supervised role.
Every trial shown is one this guideline actually cites: each link was checked against the guideline's own reference list, and the few that a machine cannot match, a trial cited through a later follow-up, or a NICE guideline, which carries no DOI, were verified by hand against the full text. This is not the guideline's complete reference list, only the landmark trials it cites that our register holds.